Chromium Measured at 308.91 ppm in One Golfer’s Glove
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional activity or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.
Reader question: What did this exact paper measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | One 27-year-old professional woman golfer with recurrent bilateral hand plaques associated with prolonged glove use. |
| Design | Case report with standard and own-glove patch testing plus chromium analysis of the glove. |
| Comparator | Strong potassium-dichromate and glove-fragment reactions; no control golfer or chromium-free glove challenge. |
| Timepoint | Several years of recurrence; no recurrence was reported during six months after switching to chromium-free leather gloves. |
| Key result | The glove contained 308.91 ppm chromium; testing and exposure history supported chromium-tanned leather as the relevant source. |
| Funding/conflict context | Funding and author conflicts were not stated in the PubMed abstract. |
What was actually measured?
The glove contained 308.91 ppm chromium; testing and exposure history supported chromium-tanned leather as the relevant source.
The measured material concentration and six-month exposure-change observation strengthen this individual attribution without creating a general glove-risk estimate.
The denominator defines the claim. A diagnostic case, a patch-test reaction, a material analysis and a population rate answer different questions. None should be silently converted into another.
What the result does not prove
One case with treatment and glove changes cannot separate every contributor or prove a universal safe material threshold.
Temporal or anatomic alignment can strengthen an exposure hypothesis, but it does not automatically prove individual causation. Referral patterns, prior sensitization, friction, sweat, occlusion, cleaning products, adhesives, metals, rubber additives and equipment age may all shape the finding.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the paper’s conclusions, this interpretation or any product.
Keep the condition categories separate
Dryness, friction injury, irritant dermatitis, allergic contact dermatitis, infection and swelling are not interchangeable. Patch testing evaluates delayed contact allergy; it does not diagnose every rash or replace clinician judgment.
Rapid facial or throat swelling, breathing difficulty, spreading redness, drainage, fever, severe pain, widespread blistering or loss of function requires prompt medical assessment. Do not deliberately re-expose yourself to suspected equipment or chemicals.
Activity and exposure details worth documenting
- Exact equipment, surface, material, adhesive, cleaner, glove, shoe, strap or instrument touching the area.
- Location and shape of the skin change relative to the contact site.
- Time from exposure to symptoms, and what changed during rest or avoidance.
- Sweat, friction, pressure, wetness, occlusion, ultraviolet exposure and cleaning routines.
- Manufacturer material disclosures, workplace safety data and clinician-directed testing—not self-testing.
Prevention comes before cosmetic care
Prevention must match the hazard: fit and friction control, material substitution, protective equipment, engineering controls, occupational-health review and clinician-guided allergen avoidance. Never apply workplace or sports chemicals directly to skin to “test” them.
Primary research and authoritative guidance
- Primary research record: PubMed PMID 20548885
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: contact dermatitis
- American Academy of Dermatology: dry-skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This paper did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, allergy, infection, blisters or swelling; relieves pain or itch; neutralizes an allergen; is appropriate for every person; or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Personal UV Dose in 10 Young Skiers
- UV-Prevention Practices Reported by 1,200 Outdoor-Sport Coaches
- Epoxy Allergy in One Golf-Club Repair Worker
- Colophony Allergy in One Ballet-Company Masseur
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation, product-safety determination or occupational clearance.